汉族精神分裂症患者的错配负性:一项荟萃分析

Yanbing Xiong, Xianbin Ll, Lei Zhao, Chuanyue Wang
{"title":"汉族精神分裂症患者的错配负性:一项荟萃分析","authors":"Yanbing Xiong,&nbsp;Xianbin Ll,&nbsp;Lei Zhao,&nbsp;Chuanyue Wang","doi":"10.11919/j.issn.1002-0829.217103","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous meta-analysis revealed that mismatch negativity(MMN) amplitude decreased in patients with schizophrenia compared with healthy controls (Cohen's d, d about 1), leading to the possibility of mismatch negativity being used as a biomarker for schizophrenia. However, it is unknown whether MMN is reliably changed in Chinese patients. It is necessary to carry out a meta-analysis on MMN of Han Chinese patients with schizophrenia.</p><p><strong>Aim: </strong>To investigate whether MMN could be used as a biomarker for Han Chinese patients with schizophrenia.</p><p><strong>Methods: </strong>A literature search was conducted to identify clinical trials on MMN in Han Chinese schizophrenia patients published before May 8, 2017, by searching the Chinese language databases CNKI, WanFang Data, VIP Data and PubMed. The effects of MMN deficits were evaluated for MMN amplitude by calculating standard mean difference (SMDs) between schizophrenia patient groups and healthy control groups.</p><p><strong>Results: </strong>A total of 11 studies were included in the analysis. The total quality of all the studies were more than 6 as evaluated by Newcastle-Ottawa Scale (NOS). Meta-analysis of data from these studies had a pooled sample of 432 patients with schizophrenia and 392 healthy controls. There exists significant MMN deficit in schizophrenia patients compared to healthy controls (Cohen's <i>d</i>=1.004). When studies were excluded due to heterogeneity, the pooled effect size of the MMN differences between the patient group and healthy controls dropped to 0.79 (Cohen's <i>d</i>=0.79). Subgroup analysis showed that MMN amplitude deficits of schizophrenia over three years had the pooled effect size of 0.95, and less than three years had the pooled effect size of 0.77. Publication bias conducted via Egger regression test (<i>t</i> = 1.83; p = 0.101), suggested that there was no publication bias.</p><p><strong>Conclusion: </strong>The effect size of MMN amplitude between Chinese patients with schizophrenia and healthy controls is consistent with other meta-analyses published on this topic, suggesting that Han Chinese patients with schizophrenia also exhibited MMN deficits.</p>","PeriodicalId":21886,"journal":{"name":"上海精神医学","volume":"29 5","pages":"259-267"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/6e/sap-29-259.PMC5738514.pdf","citationCount":"2","resultStr":"{\"title\":\"Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.\",\"authors\":\"Yanbing Xiong,&nbsp;Xianbin Ll,&nbsp;Lei Zhao,&nbsp;Chuanyue Wang\",\"doi\":\"10.11919/j.issn.1002-0829.217103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Previous meta-analysis revealed that mismatch negativity(MMN) amplitude decreased in patients with schizophrenia compared with healthy controls (Cohen's d, d about 1), leading to the possibility of mismatch negativity being used as a biomarker for schizophrenia. However, it is unknown whether MMN is reliably changed in Chinese patients. It is necessary to carry out a meta-analysis on MMN of Han Chinese patients with schizophrenia.</p><p><strong>Aim: </strong>To investigate whether MMN could be used as a biomarker for Han Chinese patients with schizophrenia.</p><p><strong>Methods: </strong>A literature search was conducted to identify clinical trials on MMN in Han Chinese schizophrenia patients published before May 8, 2017, by searching the Chinese language databases CNKI, WanFang Data, VIP Data and PubMed. The effects of MMN deficits were evaluated for MMN amplitude by calculating standard mean difference (SMDs) between schizophrenia patient groups and healthy control groups.</p><p><strong>Results: </strong>A total of 11 studies were included in the analysis. The total quality of all the studies were more than 6 as evaluated by Newcastle-Ottawa Scale (NOS). Meta-analysis of data from these studies had a pooled sample of 432 patients with schizophrenia and 392 healthy controls. There exists significant MMN deficit in schizophrenia patients compared to healthy controls (Cohen's <i>d</i>=1.004). When studies were excluded due to heterogeneity, the pooled effect size of the MMN differences between the patient group and healthy controls dropped to 0.79 (Cohen's <i>d</i>=0.79). Subgroup analysis showed that MMN amplitude deficits of schizophrenia over three years had the pooled effect size of 0.95, and less than three years had the pooled effect size of 0.77. Publication bias conducted via Egger regression test (<i>t</i> = 1.83; p = 0.101), suggested that there was no publication bias.</p><p><strong>Conclusion: </strong>The effect size of MMN amplitude between Chinese patients with schizophrenia and healthy controls is consistent with other meta-analyses published on this topic, suggesting that Han Chinese patients with schizophrenia also exhibited MMN deficits.</p>\",\"PeriodicalId\":21886,\"journal\":{\"name\":\"上海精神医学\",\"volume\":\"29 5\",\"pages\":\"259-267\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/6e/sap-29-259.PMC5738514.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"上海精神医学\",\"FirstCategoryId\":\"95\",\"ListUrlMain\":\"https://doi.org/10.11919/j.issn.1002-0829.217103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"上海精神医学","FirstCategoryId":"95","ListUrlMain":"https://doi.org/10.11919/j.issn.1002-0829.217103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景:先前的荟萃分析显示,与健康对照组相比,精神分裂症患者的错配负性(MMN)振幅降低(Cohen's d, d约为1),这可能导致错配负性被用作精神分裂症的生物标志物。然而,MMN在中国患者中是否发生了可靠的改变尚不清楚。有必要对汉族精神分裂症患者的MMN进行meta分析。目的:探讨MMN是否可作为汉族精神分裂症患者的生物标志物。方法:通过检索中文数据库CNKI、万方数据、VIP数据和PubMed,检索2017年5月8日前发表的MMN治疗汉族精神分裂症患者的临床试验。通过计算精神分裂症患者组与健康对照组之间的标准平均差(SMDs)来评估MMN缺陷对MMN振幅的影响。结果:共纳入11项研究。采用纽卡斯尔-渥太华量表(NOS)评价,所有研究的总质量均在6分以上。这些研究数据的荟萃分析汇集了432名精神分裂症患者和392名健康对照者。与健康对照组相比,精神分裂症患者存在显著的MMN缺失(Cohen’s d=1.004)。当由于异质性而排除研究时,患者组和健康对照组之间MMN差异的综合效应大小降至0.79 (Cohen’s d=0.79)。亚组分析显示,精神分裂症3年以上的MMN振幅缺陷合并效应量为0.95,小于3年的合并效应量为0.77。Egger回归检验发表偏倚(t = 1.83;P = 0.101),提示无发表偏倚。结论:中国精神分裂症患者和健康对照之间MMN振幅的效应大小与其他发表的关于该主题的荟萃分析一致,表明汉族精神分裂症患者也表现出MMN缺陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.

Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.

Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.

Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.

Background: Previous meta-analysis revealed that mismatch negativity(MMN) amplitude decreased in patients with schizophrenia compared with healthy controls (Cohen's d, d about 1), leading to the possibility of mismatch negativity being used as a biomarker for schizophrenia. However, it is unknown whether MMN is reliably changed in Chinese patients. It is necessary to carry out a meta-analysis on MMN of Han Chinese patients with schizophrenia.

Aim: To investigate whether MMN could be used as a biomarker for Han Chinese patients with schizophrenia.

Methods: A literature search was conducted to identify clinical trials on MMN in Han Chinese schizophrenia patients published before May 8, 2017, by searching the Chinese language databases CNKI, WanFang Data, VIP Data and PubMed. The effects of MMN deficits were evaluated for MMN amplitude by calculating standard mean difference (SMDs) between schizophrenia patient groups and healthy control groups.

Results: A total of 11 studies were included in the analysis. The total quality of all the studies were more than 6 as evaluated by Newcastle-Ottawa Scale (NOS). Meta-analysis of data from these studies had a pooled sample of 432 patients with schizophrenia and 392 healthy controls. There exists significant MMN deficit in schizophrenia patients compared to healthy controls (Cohen's d=1.004). When studies were excluded due to heterogeneity, the pooled effect size of the MMN differences between the patient group and healthy controls dropped to 0.79 (Cohen's d=0.79). Subgroup analysis showed that MMN amplitude deficits of schizophrenia over three years had the pooled effect size of 0.95, and less than three years had the pooled effect size of 0.77. Publication bias conducted via Egger regression test (t = 1.83; p = 0.101), suggested that there was no publication bias.

Conclusion: The effect size of MMN amplitude between Chinese patients with schizophrenia and healthy controls is consistent with other meta-analyses published on this topic, suggesting that Han Chinese patients with schizophrenia also exhibited MMN deficits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
2341
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信